...
首页> 外文期刊>BMC Gastroenterology >Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma
【24h】

Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma

机译:浅表食管鳞状细胞癌完全圆形内镜下黏膜下剥离术后的食管狭窄处理

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Endoscopic submucosal dissection (ESD) permits removal of esophageal epithelial neoplasms en bloc, but is associated with esophageal stenosis, particularly when ESD involves the entire circumference of the esophageal lumen. We examined the effectiveness of systemic steroid administration for control of postprocedural esophageal stricture after complete circular ESD. Methods Seven patients who underwent wholly circumferential ESD for superficially extended esophageal squamous cell carcinoma were enrolled in this study. In 3 patients, prophylactic endoscopic balloon dilatation (EBD) was started on the third post-ESD day and was performed twice a week for 8 weeks. In 4 patients, oral prednisolone was started with 30 mg daily on the third post-ESD day, tapered gradually (daily 30, 30, 25, 25, 20, 15, 10, 5 mg for 7 days each), and then discontinued at 8 weeks. EBD was used as needed whenever patients complained of dysphagia. Results En bloc ESD with tumor-free margins was safely achieved in all cases. Patients in the prophylactic EBD group required a mean of 32.7 EBD sessions; the postprocedural stricture was dilated up to 18 mm in diameter in these patients. On the other hand, systemic steroid administration substantially reduced or eliminated the need for EBD. Corticosteroid therapy was not associated with any adverse events. Post-ESD esophageal stricture after complete circular ESD was persistent, requiring multiple EBD sessions. Conclusions Use of oral prednisolone administration may be an effective treatment strategy for reducing post-ESD esophageal stricture after complete circular ESD.
机译:背景技术内镜下黏膜下剥离术(ESD)可以整批切除食管上皮肿瘤,但与食管狭窄有关,特别是当ESD涉及食管腔的整个圆周时。我们检查了全身性类固醇给药在完全循环ESD后控制食道后狭窄的有效性。方法选择7例行全周ESD治疗的浅表性食管鳞状细胞癌患者。在3例患者中,预防性内镜下球囊扩张术(EBD)在ESD后的第三天开始,每周两次,共8周。在4例患者中,口服泼尼松龙在ESD后的第三天开始以每天30 mg的剂量开始服用,并逐渐逐渐减少(每天30、30、25、25、25、20、15、10、5 mg,每次7天),然后在8个星期。患者抱怨吞咽困难时,可根据需要使用EBD。结果在所有情况下均可安全地实现无肿瘤边缘的整体ESD。预防性EBD组的患者平均需要32.7次EBD疗程。这些患者的手术后狭窄扩大至直径18 mm。另一方面,全身性类固醇给药大大减少或消除了对EBD的需要。皮质类固醇激素治疗与任何不良事件无关。完全循环ESD后,ESD后食管狭窄仍然存在,需要多次EBD疗程。结论口服强的松龙口服给药可能是减少完全循环ESD后ESD后食管狭窄的有效治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号